Garsun 60 mg Powder and solvent for solution for injection.
PDF Leaflet Revision Date: 03 April 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of severe malaria caused by Plasmodium falciparum.
Dosage (summary)
Adults: 2.4 mg/kg IV/IM at 0, 12, 24 hours, then daily. Children: 3 mg/kg IV/IM at 0, 12, 24 hours, then daily.
Onset of Action / Duration
Onset: Rapid, Duration: Until oral treatment can be substituted.
Special Populations
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Administer without delay in pregnancy; limited adverse effects noted. Excreted in breast milk, not expected to harm infants.
Contraindications
- Hypersensitivity to artesunate or excipients
Common side effects
- Dizziness
- Light-headedness
- Rash
- Nausea
- Vomiting
Counselling Points
- Monitor blood glucose frequently
- Follow-up for delayed haemolysis
- Use immediately after reconstitution
Serious warnings
- Severe malaria is a medical emergency
- Risk of neurological sequelae
- Post-treatment haemolytic anaemia
Important Disclaimer
The Garsun 60 mg Powder and solvent for solution for injection. professional information leaflet below is the property of Equity Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
